How long patients have been followed and safety concerns

Researchers say they have, for the first time, dramatically slowed the progression of a cruel and devastating neuron condition called Huntington’s disease.

For sufferers, this potentially means getting years of their life back or the lessening of symptoms of a condition that robs them of physical movement and kills their brain cells.

Today, Professor Julie Stout from Monash University’s Turner Institute of Brain and Mental Health, on why this clinical trial, which involved a small number of patients in London, has the medical world so excited.

Subscribe to The Age & SMH: https://subscribe.smh.com.au/

See omnystudio.com/listener for privacy information.